Donor lymphocyte infusion combined with azacitidine after allogeneic HSCT in pediatric AML: a single-center retrospective analysis

IntroductionDonor lymphocyte infusion (DLI) can enhance graft-versus-leukemia (GvL) effects following allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric acute myeloid leukemia (AML). However, the optimal integration of azacitidine (Aza) with DLI in children remains uncertain.Meth...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ana Maria Bica, Andra Daniela Marcu, Cristina Georgiana Jercan, Iuliana Iordan, Andreea Nicoleta Serbanica, Irina Avramescu, Matei Colita, Delia Codruta Popa, Ileana Constantinescu, Alexandra Mihaela Ichim, Andrei Colita, Anca Colita
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-01-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	donor lymphocyte infusion azacitidine pediatric acute myeloid leukemia hematopoietic stem cell transplantation graft-versus-leukemia graft-versus-host disease
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1727492/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!